Skip to main content
PLOS One logoLink to PLOS One
. 2023 Oct 20;18(10):e0293174. doi: 10.1371/journal.pone.0293174

Perceptions about and reasons for participation in research bronchoscopy in Uganda: A qualitative analysis

David Kaawa-Mafigiri 1,2,*,#, Mary Nsereko 2,#, Michael Odie 2,#, John L Johnson 2,3,#
Editor: Steve Zimmerman4
PMCID: PMC10588838  PMID: 37862303

Abstract

This study sought to assess perceptions towards and reasons for participation in research bronchoscopy studies in a high TB burden urban setting. Additionally, the study aimed to identify areas of pre- and post-procedural concern among healthy adults approached to participate in research bronchoscopy. A cross sectional qualitative study was undertaken at the Uganda-Case Western Reserve University Collaboration Tuberculosis Research Project Clinic at Mulago National Referral Hospital in Kampala, Uganda. In-depth interviews were conducted with participants at their pre-bronchoscopy visit (n = 17) and after they had undergone bronchoscopy (n = 23) to examine their perceptions and experiences with the procedure. Following consent, all interviews were audio recorded and later transcribed and typed in MS WORD. Local language interviews were translated into English by the social science interviewers. Qualitative analysis was performed manually following an inductive and emergent approach typical in thematic analysis. This study was approved by the Makerere University School of Social Sciences Research Ethics Committee (MAKSS REC 09.18.220) and registered with the Uganda National Council for Science and Technology (UNCST SS4785). Overall willingness to participate in bronchoscopy was high as many participants viewed the study as primarily a means of getting free health checks and determining their health status. Notably, despite extensive face to face counseling for this study coupled with the fact that our participants had been involved in prior research at the site, therapeutic misconception still played a pivotal role in willingness to participate in research bronchoscopy. Therapeutic misconception has important ethical and research implications in clinical research, which requires strategies to tackle it, even among a pool of potential participants who are knowledgeable about a disease or clinical care procedures. Continuous awareness and knowledge building about the difference between being a trial participant and therapeutic misconception must become a mainstay in trials to improve the process of informed consent for future research bronchoscopy studies.

Introduction

In Uganda, bronchoscopy with and without bronchoalveolar lavage has predominantly been used by specialist pulmonary physicians for diagnosis and clinical care [1]. Situations where it has been useful include the diagnosis of smear negative tuberculosis (TB) and other opportunistic lung infections such as pneumocystis pneumonia in HIV infected individuals, the diagnosis of lung cancer, and removal of aspirated foreign bodies [1]. The use of bronchoscopy as a research tool has mainly been limited to patients with clinical lung disease [1]. However, recent studies of healthy individuals exposed to patients with TB have begun to examine human protective immune responses against TB [2, 3]. Little is known about the reasons that motivate otherwise healthy individuals to undergo or decline research bronchoscopy.

Previous exploration of reasons for participation in research bronchoscopy studies among volunteers in Africa [2]. Europe and the United States revealed personal benefit, including health assessment, perceived future access to health care when ill, and remuneration as factors influencing willingness to undergo bronchoscopy. Studies also suggest that altruistic reasons including the desire to help current or future patients with lung diseases are common motivations for participation. On the other hand, inconvenience associated with research and fear of procedures, have been considered as barriers to participation [2, 46]. Regardless of the motivation or barriers to participation, it is vital to understand the factors underlying these choices to improve quality of research participation and engagement. Understanding factors that influence choices about participation in research bronchoscopy will inform researchers about areas of concern and causes of anxiety in potential research participants. This knowledge may also contribute to ensuring informed consent for participation in research bronchoscopy. Attaining informed consent requires an understanding of the design and content of materials used to deliver and share information (making informed consent more relevant to the participants) and working with participants before, during, and after research bronchoscopy. The Uganda-Case Western Reserve University Research Collaboration (UCRC) is a long-standing research collaboration between Makerere University in Kampala, Uganda and Case Western Reserve University, Cleveland, U.S. The Collaboration began performing research bronchoscopy with bronchoalveolar lavage in healthy adults in Uganda in December 2017 to obtain cells from the lungs for studies of human immunity against TB in household contacts exposed to patients with active TB. These studies examine the immunopathogenesis of TB infection and progression to active TB in HIV-infected and–uninfected individuals. To improve participant knowledge about research bronchoscopy, assure informed consent and allay participant anxiety, the investigators involved social scientists to interview participants and collect information about their perceptions and experience with research bronchoscopy.

Objectives

This study sought to assess perceptions towards and reasons for participation in research bronchoscopy studies by healthy adults in a high TB burden urban setting. Additionally, the study aimed to identify areas of pre- and post-procedural concern among healthy adults approached to participate in research bronchoscopy.

Materials and methods

Study setting

A cross sectional qualitative study was undertaken in 2019 at the UCRC Research Project Clinic at Mulago National Referral Hospital in Kampala, Uganda. UCRC is a research collaboration between Makerere University in Kampala and Case Western Reserve University in Cleveland, US with over 30 years of experience conducting clinical and other health sciences research in TB, HIV and other non-infectious diseases. The authors have been conducting research with the UCRC for various lengths of time in the past ranging between 15–32 years. They oversaw this current study’s procedures including participant recruitment, interviewer selection and data collection. In-depth interviews were conducted with participants at their pre-bronchoscopy visit (n = 17) and after they had undergone bronchoscopy (n = 23) to examine their perceptions and experiences with the procedure. The interviews were conducted by two trained social scientists with previous experience in health services research including previous social science studies conducted at UCRC. The interviewers spoke both English and Luganda, the most widely spoken local language in the study area. The interviewers were supervised for quality control by both the Clinic Director and the Principal Investigator who is an Anthropologist and senior social science researcher at UCRC.

Study procedures

Adult participants in an ongoing cross-sectional observational study of the immunopathogenesis of TB in individuals who did or did not become infected with M. tuberculosis after being exposed to a person in their household with active pulmonary TB who had given their permission to be contacted about additional TB research studies were contacted about participating in a study of blood and lung immune responses against TB that included research bronchoscopy with bronchoalveolar lavage and a research blood collection. After giving informed consent, volunteers underwent a history and physical examination, a chest radiograph to exclude active TB or other clinical lung disease, and complete blood count, chemistry, and coagulation testing. Full details are described elsewhere [7]. Participants were scheduled for a pre-bronchoscopy visit three days before the procedure, a bronchoscopy visit, and a post bronchoscopy visit three days after the procedure.

For this qualitative study, two social scientists independent of the clinic staff who provided care to research participants of the parent bronchoscopy study approached the participants at the pre bronchoscopy visit to seek their interest in the study. Willing participants were consented, enrolled and interviewed. The consent included a second follow up interview at the post bronchoscopy visit three days after the procedure.

Participants were interviewed in the language of their choice, either Luganda or English using an interview guide. Staff at the TB clinic worked with the social scientists to schedule interviews during both the pre and post bronchoscopy visits. Interviews were held with individual participants in a comfortable private room that ensured privacy and confidentiality.

All interviews were audio recorded and later transcribed and typed in MS WORD. Local language interviews were translated into English by the social science interviewers.

Logistical constraints and interview scheduling led to some participants not having both pre and post bronchoscopy interviews. Of the 6 participants who had only a pre-bronchoscopy interview, 4 were ineligible for and did not undergo the bronchoscopy procedure consequent to out of range screening laboratory test results. The participants who were scheduled and available for a post bronchoscopy visit but had missed the pre-bronchoscopy interview were retrospectively interviewed about their pre bronchoscopy perceptions.

Analysis

Qualitative analysis was performed manually following an inductive and emergent approach typical in thematic analysis [8]. Data was coded and organized through indexing or measurement device to assign values to the text. Drawing from the broader reflexive thematic analytical strategy [9, 10], we relied on the ‘codebook approach’ to develop a codebook (see attached supplementary material). Two research assistants independently coded data with a third (study researcher) acting to determine consensus during discussions as a team. The codebook was then pilot tested on 10 interviews (5 from pre- and 5 from post-broncho participants) before finalizing it. The coding process was iterative and ongoing and used some a priori codes selected beforehand and in vivo codes that emerged during analysis [8, 11]. Initially 2 coders worked independently with one single researcher synthesizing the codes into broader themes. Selected specific themes were refined further to develop a final list of themes and theme definition. Some codes that were set a priori focused on what can be changed, reasons for participating in a bronchoscopy study, and advice to other people who might participate in bronchoscopy. These a priori codes were influenced by adaptations from the health belief model [12, 13] which posits that individuals will seek care (alter their behavior) once the perceived risk to their health (susceptibility to a condition like TB) supersedes other alternatives, including ‘riding it out’ (if a condition is not severe), self-medication or treatment (usually when they cannot afford associated costs).

The pre-bronchoscopy interviews focused on experiences if this was their first time to participate in this kind of study, at what age they started participating in this kind of research, their relationship with any person that had TB, and their feelings towards bronchoscopy. An in depth review of the literature on the acceptability and perceptions about research bronchoscopy was also conducted and helped to generate some codes. Our literature review included recent studies on this topic including studies done in low and middle income studies and tuberculosis.

Ethical approvals

This study was approved by the Makerere University School of Social Sciences Research Ethics Committee (MAKSS REC 09.18.220) and registered with the Uganda National Council for Science and Technology (UNCST SS4785). All participants gave written informed consent for study participation.

Results

Of the 31 participants interviewed for this study, 17 (55%) were male and 28 (90%) were aged less than 30 years. Nine (29%) of the participants had both a pre and post bronchoscopy interview (Table 1).

Table 1. Demographic characteristics of participants.

Characteristic f %
(n = 31)
Sex
    Male 17 55
    Female 14 45
Age
    21–30 years 28 90
    Above 30 years 3 10
KII Conducted
    Pre Bronchoscopy only 8 26
    Post Bronchoscopy only 14 45
    Both Pre & Post Bronchoscopy 9 29

Mean age 25.7 ± 6.2; Min 19; Max 45; Median 25.

The major themes that emerged for willingness to participate in research bronchoscopy as derived from reasons for participation were prior experience of TB having witnessed the suffering and healing process of loved ones as they underwent care from the UCRC; a need to ‘know their health status’ given the range of tests and other care procedures associated or anticipated with being a participant on the study; and therapeutic misconception about gaining treatment despite being healthy adults without TB. An important theme was the willingness to participate for altruistic reasons indicating the appreciation of how research may help generate important knowledge for future health care technology and services.

Reasons for participation

Many participants (n = 13) reported that their motivation to undergo research bronchoscopy was due to the care a loved member in their social network had received previously at the health facility. For some, their parents, other relatives, or friends had received free medical care services for TB treatment.

The other reason why I participated in this research bronchoscopy was that my husband was treated from here at no cost and he got better… Aaaah I was thanking them because I was grateful for what they did for us (Female, Post Bronchoscopy)

What gave me the courage? I think of course I had that fear but when I sat back and remembered when my dad was ill, we literally got free treatment and these guys were with him until he got better and he had to go back to work. Free treatment, and that medicine was really, really expensive you should go to [know what is in] private hospitals, we tried to do research outside and it was expensive. It is an intensive kind of treatment that does not stop in one day or two. You can even take a full year taking tabs, but then these people aided my dad and they did not stop only on my dad but they also aided all of us (Female, Post Bronchoscopy)

To them, participating in the study was seen as ‘giving back’ to the society (altruism). Study participants emphasized that when their loved ones were sick, the UCRC clinic provided them with free medical care services that would otherwise not have been affordable.

Yes, I did it because, I had a brother who had TB way back and the organization helped to provide treatment for him and we as a family we were all joined into [recruited for follow-up] the organization for treatment because the TB drugs were expensive. So, when they explained to me that there is what they want to do with my help for the good of the TB patients, I said why shouldn’t I help, if at all they came and provided treatment for the person they did not know without giving them any money for the whole year giving him all the necessary treatment. So, I was like why shouldn’t I do this small thing such that another person benefits. That is why I decided to do it (Male, Post-bronchoscopy)

Another important reason for willingness to undergo research bronchoscopy was the anticipation that participants would receive care and treatment just in case they had TB or other related illness that may be discovered. Whereas these participants had clearly been informed that they were not TB infected, and that one of the criteria for joining the study was being a healthy adult, they appeared to perceive that by undergoing bronchoscopy, if found to have TB they would be treated. One participant narrated that:

Both parents were victims of TB, so the doctors were wondering why we did not get infected, so because of that reason they started to ‘diagnose’ us with an offer that in case they find us infected they would provide the treatment and I said to myself I cannot miss such a chance/opportunity.”(Male Post Bronchoscopy)

Other participants noted:

Why I wish to participate, I will get to know whether my health is okay, even to know my viral load “Obutafali” and even to inform my other family members those that we have been receiving treatment with that I am normal or I have the TB infection like my uncle, my sibling and others so that they get strong. Because the other week my uncle requested me to come to help him know the truth whether I am infected or not, this will help them to get stronger as me being their example(Female, Pre Bronchoscopy)

The reason is that I want to know whether I am infected with TB or not because the outside may not show yet when inside is examined it might be seen. What I expect is to get results telling me whether I am sick inside or not; I hope to get those results (Female, Pre Bronchoscopy)

We note that our study population comprised of household contacts of an index TB patient and as such participants likely had some experience with seeing the severity of TB among other household members. For instance, many had reported seeing their loved ones suffer from effects of TB, possibly influencing their perception that if they participated in the study, they too might benefit from those trial procedures. Other participants, who knew that they were healthy at the time they volunteered for the research bronchoscopy study expressed gratitude for TB care given to their family members, loved ones and others in their local community by the UCRC TB Project Clinic. As such they were motivated to participate in support of their loved ones.

The reason why I did accept to have bronchoscopy done was because my father had TB, he came here and was treated and got cured at no cost. So I did this because if my father was here as a TB patient and he was treated by Mulago [Hospital name housing the UCRC] Tuberculosis why don’t I do the same if I am called upon? The other reason is because I also used to come here for treatment although I was not infected with TB. Therefore I did this for my parent (Male, Post Bronchoscopy)

Overall, many people reported participating due to therapeutic misconception. Therapeutic misconception among research subjects occurs when they do not distinguish between clinical research and ordinary treatment, and therefore inaccurately attribute therapeutic intent to research procedures in the clinical studies they participate in [1416].

Five respondents agreed to participate in the bronchoscopy study because the health workers (counselors, nurses and doctors) had reportedly informed them that they were trying to discover a drug that helps in curing TB. Participants stressed that this was an important stage as it will help reduce the number of people dying from TB in Uganda and other parts of the world.

The desire to ‘know their health statuses’ was another important reason given for participation in bronchoscopy. Given the fact that the study involved a number of screening procedures including laboratory tests, participants were keen to know their health status. This kept them active, throughout the whole study. And as medical test results were always returned and interpreted to the study participants, this encouraged them to proceed to a next level and as such complete the bronchoscopy procedure.

I like this proverb that… (How do you call it); prevention is better than cure. So, when I come, they check me, see what is inside my lungs, the oxygen in my blood, the pressure. So that helps me to know my health status and I was curious about it so I had to come in (accept to participate in bronchoscopy). (Female, Post-bronchoscopy)

Some participants (n = 3) pointed out that their motivation to participate in research bronchoscopy was love of adventure and desire to make history. They wanted to be remembered for having played a big role in the discovery of TB drugs in Uganda. Their participation was attributed to the fact they want to be affiliated with a group of researchers working towards the discovery of a TB drug.

Okay I am a learned person and I know the importance of research. I would like to be part of the research, big research that will help people. Sometimes you can do research and it is just for news but this is not for news. It will help people once it becomes successful. So, I am one person who can help among all so I cannot just be there yet I can help to save as many people as this. So, the most important thing is that this study will not be harmful to my body, that is what matters most. (Female, Post-bronchoscopy)

I was very happy [to participate] because I thought they want me to stay safe from diseases (Male, Post-bronchoscopy)

Perception of bronchoscopy

The majority of participants (n = 12), who had undergone bronchoscopy considered it largely satisfactory and acceptable. They pointed out that they did not have any major discomfort or problems during and after the procedure. They were willing to participate in future research including studies involving research bronchoscopy. Some respondents (n = 5) reported experiencing transient discomfort during bronchoscopy, especially when inserting the bronchoscope through the nose and into the throat and lungs. Even those who had not yet undergone/experienced bronchoscopy had the same fear of discomfort associated with inserting the tube.

Some participants found it very hard to convince their relatives and friends that they were going to participate in a study involving an invasive procedure like bronchoscopy. Some reported leaving their homes to attend the clinic for bronchoscopy without informing their relatives or family members where they were going or why. One participant pointed out that her parents had threatened to denounce her as their daughter if she participated in the bronchoscopy study; however, this didn’t stop her from participating in the study. She attributed her resolve to the confidence and trust she had gained from the medical doctors.

I was informed by my parents that if I participate in this study, I cease being their daughter and they are not responsible for any complication that might result from the bronchoscopy participation. But the health workers had assured me that I will not have any complications so I escaped and participated. (Female, Post-bronchoscopy)

This illustrates that, while some participants view bronchoscopy as acceptable, there remains negative perceptions towards bronchoscopy in the community as they think it might lead to serious health consequences.

Some participants (n = 3) perceived the bronchoscopy and the required pre- and post-procedure visits to be time consuming which interfered with their work schedules. They suggested that the process needs to be shortened so that it did not become disruptive to their work schedules.

There was a challenge because there was where I was working from and as an employee, I was missing work for some days and they threatened to dismiss me. (Female, Post-broncho)

A number of participants mentioned the desire to help the researchers achieve their goal and help their fellow man in the future

“…My primary goal is when the research has been successful. I don’t care how long it will take but I want to know that I was helpful(Male, Pre-broncho)

“First and foremost I want to help them with the research they are carrying because there are many people with TB….so if I can be their research sample to get what they want that is the one reason I am taking part in the study(Female, Pre-bronchoscopy)

“I feel this is the way of rewarding and giving back to the community and regarding the reasons why they are doing this research(Female, Pre-bronchoscopy)

Discussion

This study aimed at determining the perceptions and reasons for participating in a research bronchoscopy study among healthy adults who were household contacts of TB patients in Kampala. Overall willingness to participate in bronchoscopy was high as many participants viewed the study as primarily a means of getting free health checks and determining their health status. There appears to be an overlap among participants who may be willing to participate in bronchoscopy research as a way to learn more about their health status and gain other treatment benefits associated with being a research participant, particularly in a context of low social economic status like our study setting. For instance, at the UCRC, numerous tests including blood tests, chest radiographs, and sputum examinations for TB, and research bronchoscopy are performed on research participants and as such some participants are motivated to participate in a study due to the perceived treatment related to the research. However, all participants in our research studies receive intensive, focused consent and health education from experienced counselors, nurses and physicians that they are participating in a research study and not a TB treatment study. All participants had multiple opportunities to ask questions about the study and have their questions answered. We therefore note that the plausible therapeutic element in this case was mainly a misconception on the part of the otherwise healthy adults. This therapeutic misconception was also one of the major findings of a study done in Malawi [2]. In the context of constrained public health services at all levels in LMIC coupled with the poor socioeconomic status of participants, this finding is not surprising. What is notable is that despite adequate counseling for this study coupled with the fact that our participants had been involved in prior research at the site, therapeutic misconception still played a significant role in willingness to participate in research bronchoscopy. Therapeutic misconception has been shown to have serious ethical and research implications in trials [1416]. Future research bronchoscopy studies should consider strategies to decrease therapeutic misconception, even among a pool of potential participants who are knowledgeable about a disease or clinical care procedures.

Another commonly mentioned reason for participation was the valued clinical and social care the respondents and other members of their households had previously received at the study clinic. As mentioned earlier, the UCRC research and associated health care services has been ongoing for over 30 years in this study context. Moreover, the authors as well as the study staff have also had two or more decades of familiarity with research in the study area. We recognize that our interpretations of participants’ reasons for willingness to participate in research bronchoscopy may be influenced by our position as longstanding researchers in this area. For instance, it is possible that our understanding and interpretation of some of the narratives about willingness to participate may be borne out of our bias as longstanding researchers in the area. However, we are confident in our methodological rigor such as ensuring that we used independent, trained social science research assistants to conduct the interviews. This was done in part to improve on internal validity of the interview process. We still acknowledge that for participants, there is a possibility that the association with the UCRC broader research and treatment agenda may have overridden the efforts to ensure they answer honestly about their perceptions of research bronchoscopy.

Our study is potentially influenced by adaptations of the health belief model [12, 13] which states that individuals will seek care once they perceived risk to their health supersedes other alternatives, mainly ‘riding it out’ self-medication or treatment. Because some of the participants indicated that their willingness was influenced in part due to their prior experience seeing loved ones being treated well for TB, and the gravity of TB, it is possible that they felt a need to also participate in efforts associated with TB control. Research bronchoscopy in this case would have been perceived in that lens, and so participants may have selected to undergo the procedure having perceived TB as so severe not to engage with care. These findings illustrate the need for continuous/ongoing awareness and knowledge building about the difference between being a research participant and therapeutic misconception. This knowledge gap has implications for improving the process of informed consent for future research bronchoscopy studies. The fact that there can be blurred lines between an individual’s motivation to participate in a study due to anticipated health benefits, even when not clearly stated, and the misperception about gaining therapy despite repeated concerted effort to clarify that participation is based on being healthy and there is no direct treatment benefit to participants, further emphasizes the need to continuously provide awareness and knowledge building to potential research participants.

Our study has several limitations. Our results may not be generalizable to other settings as our participants all had prior research experience at the study site and this may have influenced their acceptability for the research bronchoscopy procedure. Moreover the study participants reside in the catchment area of the UCRC research clinic activities which in some cases means they may have encountered care directly or indirectly observed care of index TB cases in their households. Indeed, for this specific study as pointed out earlier in the methods, the participants were household contacts of a known TB case. However, our findings underscore the need for continuous education and information about research bronchoscopy even among populations that may have significant exposure to research environments. As such the process of informed consent for instance may benefit from having up-dated and ongoing assessment of reasons for and willingness to participate in research bronchoscopy.

Supporting information

S1 File. Pre broncho questionnaire.

(PDF)

S2 File. Post broncho questionnaire.

(PDF)

Acknowledgments

We thank the participants who generously gave us their time and attention to complete this study.

Data Availability

The minimal, de-identified data set underlying the results of this manuscript is located on a local server at the Uganda-Case Western Reserve University Collaboration Tuberculosis Research Project Clinic’s data center. It is now available through email (data@mucwru.or.ug) upon reasonable request, with permission and notification of the Makerere University School of Social Sciences Research Ethics Committee (MAKSS REC). Any potentially identifying patient information has been fully anonymized.

Funding Statement

The parent study was funded by grants and contracts UO1AI115642, RO1AI124348 and 75N93019C00071 from the U.S. National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Worodria W, Davis JL, Cattamanchi A, Andama A, den Boon S, Yoo SD, et al. Bronchoscopy is useful for diagnosing smear-negative tuberculosis in HIV-infected patients. The European respiratory journal. 2010;36(2):446–8. Epub 2010/08/03. doi: 10.1183/09031936.00010210 ; PubMed Central PMCID: PMC2917268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.McCallum AD, Nyirenda D, Lora W, Khoo SH, Sloan DJ, Mwandumba HC, et al. Perceptions of Research Bronchoscopy in Malawian Adults with Pulmonary Tuberculosis: A Cross-Sectional Study. PloS one. 2016;11(10):e0165734. Epub 2016/10/30. doi: 10.1371/journal.pone.0165734 ; PubMed Central PMCID: PMC5085028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Yıldırım F, Özkaya Ş, Yurdakul AS. Factors affecting patients’ comfort during fiberoptic bronchoscopy and endobronchial ultrasound. Journal of pain research. 2017;10:775–81. Epub 2017/04/25. doi: 10.2147/JPR.S118047 ; PubMed Central PMCID: PMC5386605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Martinsen EMH, Eagan TML, Leiten EO, Nordeide E, Bakke PS, Lehmann S, et al. Motivation and response rates in bronchoscopy studies. Multidisciplinary respiratory medicine. 2019;14:14. Epub 2019/05/10. doi: 10.1186/s40248-019-0178-3 ; PubMed Central PMCID: PMC6495518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Leiten EO, Eagan TML, Martinsen EMH, Nordeide E, Husebø GR, Knudsen KS, et al. Complications and discomfort after research bronchoscopy in the MicroCOPD study. BMJ open respiratory research. 2020;7(1). Epub 2020/03/11. doi: 10.1136/bmjresp-2019-000449 ; PubMed Central PMCID: PMC7064136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Park JS, Ryu JS, Lee SM, Yim JJ, Yoo CG, Kim YW, et al. Influence of additional post-bronchoscopy visit on patient satisfaction after flexible bronchoscopy. The Korean journal of internal medicine. 2010;25(4):392–8. Epub 2010/12/24. doi: 10.3904/kjim.2010.25.4.392 ; PubMed Central PMCID: PMC2997968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Thiel BA, Worodria W, Nalukwago S, Nsereko M, Sanyu I, Rejani L, et al. Immune cells in bronchoalveolar lavage fluid of Ugandan adults who resist versus those who develop latent Mycobacterium tuberculosis infection. PloS one. 2021;16(4):e0249477. Epub 2021/04/10. doi: 10.1371/journal.pone.0249477 ; PubMed Central PMCID: PMC8034721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bernard H. Research methods in anthropology: Qualitative and quantitative approaches.: Rowman Altamira; 2011. [Google Scholar]
  • 9.Braun V, Clarke V. Thematic analysis. In: Cooper H., Camic P.M., Long D.L., Panter A.T., Rindskopf D., Sher K.J. (eds.) APA Handbook of Research Methods in Psychology, Research Designs, vol. 2, pp. 57–71. American Psychological Association, Washington: (2012): American Psychological Association; 2012. [Google Scholar]
  • 10.Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qualitative research in sport, exercise and health. 2019;11(4):589–97. [Google Scholar]
  • 11.Schensul SL SJ, LeCompte MD. Essential ethnographic methods: Observations, interviews, and questionnaires.: Rowman Altamira;; 1999. [Google Scholar]
  • 12.Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health belief model. Health education quarterly. 1988;15(2):175–83. doi: 10.1177/109019818801500203 [DOI] [PubMed] [Google Scholar]
  • 13.Abraham C, Sheeran P. The health belief model. Predicting health behaviour: Research and practice with social cognition models. 2015;2:30–55. [Google Scholar]
  • 14.Lidz CW, Appelbaum PS. The therapeutic misconception: problems and solutions. Medical care. 2002;40(9 Suppl):V55–63. Epub 2002/09/13. doi: 10.1097/01.MLR.0000023956.25813.18 . [DOI] [PubMed] [Google Scholar]
  • 15.Henderson GE, Churchill LR, Davis AM, Easter MM, Grady C, Joffe S, et al. Clinical trials and medical care: defining the therapeutic misconception. PLoS medicine. 2007;4(11):e324. Epub 2007/11/30. doi: 10.1371/journal.pmed.0040324 ; PubMed Central PMCID: PMC2082641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.de Melo-Martín I, Ho A. Beyond informed consent: the therapeutic misconception and trust. Journal of medical ethics. 2008;34(3):202–5. Epub 2008/03/05. doi: 10.1136/jme.2006.019406 . [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Dario Ummarino, PhD

9 Mar 2023

PONE-D-23-01054Perceptions about and reasons for participation in research bronchoscopy in Uganda: a qualitative analysisPLOS ONE

Dear Dr. Mafigiri,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Your manuscript has been comprehensively  assessed by one reviewer, and their full report is available below. The reviewer appreciated the research question of your study and the importance of your findings, but they also raised several points about methodology reporting and data analysis, as well as the discussion of the results. Please carefully address all concerns raised. 

We are issuing a decision on your manuscript at this point to prevent further delays in the evaluation of your manuscript. Please be aware that the editor who handles your revised manuscript might find it necessary to invite additional reviewers to assess this work once the revised manuscript is submitted. However, we will aim to proceed on the basis of this single review if possible. 

Please submit your revised manuscript by Apr 23 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Dario Ummarino, PhD

Senior Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for stating the following financial disclosure:

“The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

At this time, please address the following queries:

a)        Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

b)        State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c)        If any authors received a salary from any of your funders, please state which authors and which funders.

d)        If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“The parent study was funded by grants and contracts UO1AI115642, RO1AI124348 and 75N93019C00071 from the U.S. National Institutes of Health.”

We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

5. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

6. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The background and concept for this qualitative exploration of research participants' motives for undoing research bronchoscopy is excellent - the kind of qualitative research which should accompany all clinical research programmes. The engagement of locally embedded social scientists strengthens both the rationale and the methodological rigour of the work, and I think the findings are valuable and worthy of sharing.

The early part of the paper is very convincing, and the background exploration is succinct and well written. The key aspects of the paper that I think need developing are the methods and the results sections - which will have a knock-on effect on the discussion section.

From the information provided this study was well established and delivered, and I have no reason to doubt either the quality of breadth of the data collected by the research team. However, there are aspects missing which i think are essential:

1. A reflexivity statement from the authors explaining who they are, their background, and how this shapes both the questions asked and the likely way in which the interviews generated data. This needs contextualising in Uganda and the way people engage with hierarchy and research activities. I think the key to interpreting qualitative data is in understanding any potential biases or confounding factors in the data - why might the research participants chosen give the particular answers they did to these researchers at this time and in this context? Might an alternative study find different accounts (for example if interviewing them in their home setting, or in a group?) and why might these accounts vary? Would a different research team find different results because of the nature of the interviewers?

2. The details of the analysis are too thin for me at the moment. All the right work has been done, but I need to better understand the a priori codes and where they came from, how the literature was reviewed, what research team experience went into them etc. The a priori codes are so important as they expose the underlying logic model of the research team, the results they might 'expect' to find and the existing themes within the literature. The literature review methods is also essential - was this systematic or narrative, and how might any biases in it inform these a priori codes? Following this, I think it's important to see a bit more of the code book, the themes that began and then emerged, and how they were grouped and/or abandoned to come up with the final themes.

3. Developing this point, I think a clear understanding of the analysis technique would help. there are now som many variations on reflexive thematic analysis and it can be useful to understand which variant was chosen and why. If theme generation is they key, these themes need to be clearly listed and defended (sometimes a rich infographic is best for these to try to show how they interact with each other and with any overarching or meta themes).

4. These themes then need to pull through more strongly into the results and discussion. At the moment, the statements are quite weak 'some participants responded...' and even where the number is quoted such as n=12 this does not really convey how strongly these points were made in the data. I also felt the need to really understand more what people said (I suspect no respondent actually used the words 'therapeutic misconception' so it is really important to see how this term emerged from their lived experiences). The quotes used are excellent but a little sparse. Could there be more in accompanying data if space does not permit longer quotes in the body text?

5. The core notion of therapeutic misconception I felt needed more unpacking. To the newcomer, this sounds like people thinking they are going to get treatment which they are not. However it seems to overlap with people using research participation to understand more about their own health, which is not seemingly the same thing. Having a load of blood tests and a bronco definitely will tell you something about your health, even if not therapeutic - I wonder where these boundaries lie. Did some participants really think they were going to get better as a result of the branch study? Presumably in the ethics for the study, and health issue which is identified must then also be treated or referred - so in essence maybe there is a valid therapeutic element to participating? Is this then a misconception or simply a different perspective?

Trying to bring these points together, I feel as though there needs to be some revision to help the interested reader get closer to the lived experience of the participants, and then understand the inferences drawn by the research team to synthesise these into generalisable concepts. This mostly involves a more detailed account of the data creation and analysis to show how the data was obtained and processed to create these insights, but once done will prompt a sightly revised discussion section.

For all this, I reiterate that I think the paper is an excellent concept and am sure the data obtained is of a high quality - I just to need to be shown more of it!

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Oct 20;18(10):e0293174. doi: 10.1371/journal.pone.0293174.r002

Author response to Decision Letter 0


3 May 2023

PONE-D-23-01054

Perceptions about and reasons for participation in research bronchoscopy in Uganda: a qualitative analysis

PLOS ONE

Response to Reviewer Comments

Review Comments to the Author

Reviewer #1:

Comment:

1. A reflexivity statement from the authors explaining who they are, their background, and how this shapes both the questions asked and the likely way in which the interviews generated data. This needs contextualising in Uganda and the way people engage with hierarchy and research activities. I think the key to interpreting qualitative data is in understanding any potential biases or confounding factors in the data - why might the research participants chosen give the particular answers they did to these researchers at this time and in this context? Might an alternative study find different accounts (for example if interviewing them in their home setting, or in a group?) and why might these accounts vary? Would a different research team find different results because of the nature of the interviewers?

Response:

We have expanded discussion of the issues of reflexivity and potential bias to the findings due to the research context in the introduction (lines 98-100) and the study limitations section (lines 365-371). The Uganda-CWRU Research Collaboration’s (UCRC) TB Project Clinic has been in operation in this area for over 30 years. As such the chances that the study participants or their household members have previously heard about or has prior contact with health care at the clinic are high. All of the participants were household contacts of index TB patients who received TB treatment from the UCRC clinic. They may have experienced some exposure to the UCRC research and clinic operations. However we strongly believe that given the trained social scientists and study procedures to gain consent that the responses were not biased to a point where they may negatively impact the conclusions.

Comment:

2. The details of the analysis are too thin for me at the moment. All the right work has been done, but I need to better understand the a priori codes and where they came from, how the literature was reviewed, what research team experience went into them etc. The a priori codes are so important as they expose the underlying logic model of the research team, the results they might 'expect' to find and the existing themes within the literature. The literature review methods is also essential - was this systematic or narrative, and how might any biases in it inform these a priori codes? Following this, I think it's important to see a bit more of the code book, the themes that began and then emerged, and how they were grouped and/or abandoned to come up with the final themes.

Response:

Thank you for the comments on better understanding the coding process. We conducted a detailed review of the limited medical literature about perceptions and acceptability of research bronchoscopy in clinical research in low and middle income countries including correspondence and sharing of experience with investigators in Malawi and Norway who have worked in this area. We have added additional description (lines 156-160) explaining how we selected some codes a priori – from literature on the subject which we reviewed specifically from prior knowledge. We have attached our code books with this resubmission to illustrate how we reached the final themes. An extract of the codebooks could be included as supplementary material in the publication. We feel that the comment and explanations have strengthened the analysis section.

Comment:

3. Developing this point, I think a clear understanding of the analysis technique would help. there are now so many variations on reflexive thematic analysis and it can be useful to understand which variant was chosen and why. If theme generation is they key, these themes need to be clearly listed and defended (sometimes a rich infographic is best for these to try to show how they interact with each other and with any overarching or meta themes).

Response:

We have expand discussion on the analytical process (lines 143-146) as described above and included additional references (see below and references 9-10 on line 144) supporting and explaining the approach in more detail. We agree that theme generation was an important part of the analysis and has an influence on how we draw our conclusions.

The additional references are:

Braun, V., Clarke, V.: Thematic analysis. In: Cooper, H., Camic, P.M., Long, D.L., Panter, A.T., Rindskopf, D., Sher, K.J. (eds.) APA Handbook of Research Methods in Psychology, Research Designs, vol. 2, pp. 57–71. American Psychological Association, Washington (2012)

Braun, V., Clarke, V.: Reflecting on reflexive thematic analysis. Qual. Res. Sport Exerc. Health 11(4), 589–597 (2019). https:// doi. org/ 10. 1080/ 21596 76X. 2019. 16288 06

Comment:

4. These themes then need to pull through more strongly into the results and discussion. At the moment, the statements are quite weak 'some participants responded...' and even where the number is quoted such as n=12 this does not really convey how strongly these points were made in the data. I also felt the need to really understand more what people said (I suspect no respondent actually used the words 'therapeutic misconception' so it is really important to see how this term emerged from their lived experiences). The quotes used are excellent but a little sparse. Could there be more in accompanying data if space does not permit longer quotes in the body text?

Response:

We have revised the results and discussion to strengthen them and discuss the lived experiences in more depth. We have added additional vignettes to the paper to provide more insight about therapeutic misconception. The discussion now includes the important point about blurred lines between actual, plausible intent to gain some health care benefits as the UCRC clinic and the misperception that undergoing bronchoscopy as part of research was likely to lead to TB treatment. The additional text can be found in the Results (lines 178-189; 202-239) and the Discussion (lines 329-340; 356-361; 365-371).

Comment:

5. The core notion of therapeutic misconception I felt needed more unpacking. To the newcomer, this sounds like people thinking they are going to get treatment which they are not. However it seems to overlap with people using research participation to understand more about their own health, which is not seemingly the same thing. Having a load of blood tests and a bronco definitely will tell you something about your health, even if not therapeutic - I wonder where these boundaries lie. Did some participants really think they were going to get better as a result of the branch study? Presumably in the ethics for the study, and health issue which is identified must then also be treated or referred - so in essence maybe there is a valid therapeutic element to participating? Is this then a misconception or simply a different perspective?

Trying to bring these points together, I feel as though there needs to be some revision to help the interested reader get closer to the lived experience of the participants, and then understand the inferences drawn by the research team to synthesise these into generalisable concepts. This mostly involves a more detailed account of the data creation and analysis to show how the data was obtained and processed to create these insights, but once done will prompt a slightly revised discussion section.

For all this, I reiterate that I think the paper is an excellent concept and am sure the data obtained is of a high quality - I just to need to be shown more of it!

Response:

We agree with both comments 4 and 5 above and have revised and expanded the Results and Discussion. The additional text discussing therapeutic misconception can be found in the Results (lines 178-189; 202-239) and Discussion (lines 329-340; 356-361; 365-371). We have now brought the reader closer to the lived experiences by adding more quotes from the data. We have also attached the codebooks which may be provided as supplementary material for the reader to further engage with the way we engaged with the lived experiences.

Journal Requirements

When submitting your revision, we need you to address these additional requirements.

Comment:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response:

The manuscript now meets PLOS ONE's style requirements, including those for file naming.

Comment:

2. Thank you for stating the following financial disclosure:

“The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

At this time, please address the following queries:

a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution.

b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

c) If any authors received a salary from any of your funders, please state which authors and which funders.

d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Response:

We have amended the funding statements provided in the first submission and added information that was originally stated in the acknowledgements section yet it should have appeared in the funding statement. The new funding statement reads as follows:

“The parent study was funded by grants and contracts UO1AI115642, RO1AI124348 and 75N93019C00071 from the U.S. National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Comment:

3. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“The parent study was funded by grants and contracts UO1AI115642, RO1AI124348 and 75N93019C00071 from the U.S. National Institutes of Health.”

We note that you have provided additional information within the Acknowledgements Section that is not currently declared in your Funding Statement. Please note that funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Response:

We have amended the Acknowledgement section by removing funding-related text from the manuscript (lines 378-380). The new acknowledgement text reads as follows:

“We thank the participants who generously gave us their time and attention to complete this study.”

Comment:

4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

Response:

The minimal, de-identified data set underlying the results of this manuscript is located on a local server at the Uganda-Case Western Reserve University Collaboration Tuberculosis Research Project Clinic’s data center. It is now available through email (data@mucwru.or.ug) upon reasonable request, with permission and notification of the Makerere University School of Social Sciences Research Ethics Committee (MAKSS REC). Any potentially identifying patient information has been fully anonymized.

Comment:

5. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

Response:

The minimal, de-identified data set underlying the results of this manuscript is located on a local server at the Uganda-Case Western Reserve University Collaboration Tuberculosis Research Project Clinic’s data center. It is now available through email (data@mucwru.or.ug) upon reasonable request, with permission and notification of the Makerere University School of Social Sciences Research Ethics Committee (MAKSS REC). Any potentially identifying patient information has been fully anonymized.

Comment:

6. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files.

Response:

We have included our table as part of the main manuscript (lines 170-171) and removed the individual file. We have included extracts of the codebook as separate "supporting information" files under supplementary material.

Attachment

Submitted filename: Response to Reviewers.pdf

Decision Letter 1

Daniel Semakula

19 Jun 2023

PONE-D-23-01054R1Perceptions about and reasons for participation in research bronchoscopy in Uganda: a qualitative analysisPLOS ONE

Dear Dr. Mafigiri,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Aug 03 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Daniel Semakula, M.D. MPH, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Would you please respond o the comments raised by the editors and please submit the full data compilation associated with this study?

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Thanks for these careful amendments in response to my original review - they go a long way to addressing my questions. I have only minor comments in response.

1. 'A reflexivity statement from the authors'. I think my original point has been slightly missed. I have faith in the expertise of the authors and their study protocol, and do not question their conclusions. However all qualitative research has a degree of subjectivity and inherent bias, which I think needs more reflection and understanding when presenting the findings. Importantly, this does not weaken the conclusions, in my view. As the authors note, their collaboration has been running a long time and there will be a great degree of knowledge of it (as indeed comes across in the quotes). Given this, and the position of the researchers as affiliated to the programme, how might this have focussed the responses given by the participants? I would expect any person in any context to have a range of complex motivations for a given action (some implicit, some examined), underpinned by a biopsychosocial narrative about their health. What such narratives exist in Uganda? What might be the role of faith, health beliefs, and community pressure and which of these might not be volunteered to academic researchers affiliated to an established health outreach programme? The authors also started with a code book drawn from literature (as opposed to say a Community Engagement exercise) - how does this direct the interpretation of the data generated? I think it's important to identify a grounding in a given model of health, disease, and culture so that the findings are grounded in a given perspective. The few lines added do not quite address this for me and I am intrigued (for my own interest as well as academic rigour) to read what the author perceptions are as to what things they were told but also might not have been told, and why the respondents might have given that particular account at that particular time. Is it possible to see the prompting questions for the interviews?

2 & 3. 'The details of the analysis'. This is well addressed, but I still do not see a clear delineation of the final codes and themes identified at the completion of the rTA? If a thematic analysis has been perforrmed, can the authors say clearly what their final themes are and how they are linked?

4. 'These themes then need to pull through more strongly into the results and discussion'. The addition of more quotes really helps, thanks for this. I could still use some clearer signposting as to how the quotes chosen link directly to very clear thematic findings, but they very well articulate the broad discussion areas which are worked through.

5. 'The core notion of therapeutic misconception.' This was much better in this version, and I felt like I got the heart of it. The extra quotes again really helped. Annoyingly I could not see the attached codebooks on Editorial Manager which I'm sure is a software issue rather than the authors' fault!

In summary I think this remains a great paper. I still feel the need for more critical insight into the authors' views as to why they as a research team got this data, and what data they might have missed or chosen not to elicit. I'm still left with a slightly vague feeling as to the key themes the team feel they want to highlight, and how they feel these themes might be linked in a casual or narrative model. However these things are increasingly minor points, driven by a reviewer who is interested in both the subject matter and the methodology!

Reviewer #2: I am not too sure if I quite approve of this study. This is a research study done on healthy subjects and the authors have gone for an invasive procedure like bronchoscopy which could have been bypassed for non invasive or less invasive procedures maybe.The authors themselves have said there were lots of apprehensions regarding the procedure. Could they give more explicit details regarding whether they didn’t consider it necessary for a bystander to be accompanying the subject when they were doing an invasive procedure? If in case , there would have been complications in the event of bystanders not being there, how would they have dealt with it?How many subjects did not have bystanders accompanying them for the procedure? Was this point not raised by the IEC?This being a small study and going by what the authors say that it was done in a research sensitised area, the results cannot be generalised.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Oct 20;18(10):e0293174. doi: 10.1371/journal.pone.0293174.r004

Author response to Decision Letter 1


2 Aug 2023

PONE-D-23-01054R1

Perceptions about and reasons for participation in research bronchoscopy in Uganda: a qualitative analysis

PLOS ONE

Response to Reviewer Comments

Review Comments to the Author

Reviewer #1:

Comment:

Thanks for these careful amendments in response to my original review - they go a long way to addressing my questions. I have only minor comments in response.

1. 'A reflexivity statement from the authors'. I think my original point has been slightly missed. I have faith in the expertise of the authors and their study protocol, and do not question their conclusions. However all qualitative research has a degree of subjectivity and inherent bias, which I think needs more reflection and understanding when presenting the findings. Importantly, this does not weaken the conclusions, in my view. As the authors note, their collaboration has been running a long time and there will be a great degree of knowledge of it (as indeed comes across in the quotes). Given this, and the position of the researchers as affiliated to the programme, how might this have focussed the responses given by the participants? I would expect any person in any context to have a range of complex motivations for a given action (some implicit, some examined), underpinned by a biopsychosocial narrative about their health. What such narratives exist in Uganda? What might be the role of faith, health beliefs, and community pressure and which of these might not be volunteered to academic researchers affiliated to an established health outreach programme? The authors also started with a code book drawn from literature (as opposed to say a Community Engagement exercise) - how does this direct the interpretation of the data generated? I think it's important to identify a grounding in a given model of health, disease, and culture so that the findings are grounded in a given perspective. The few lines added do not quite address this for me and I am intrigued (for my own interest as well as academic rigour) to read what the author perceptions are as to what things they were told but also might not have been told, and why the respondents might have given that particular account at that particular time. Is it possible to see the prompting questions for the interviews?

Response:

Thank you for this additional clarification on the earlier comment. We appreciate the need to provide more insight and discussion about the issue of reflexivity. We note that in fact our position in the program may influence our interpretation of the participants’ views just as their responses may be influenced by the background context of their engagement with UCRC’s research and treatment agenda. As mentioned earlier, the UCRC research and associated health care services has been ongoing for over 30 years in this study context. Moreover, the authors as well as the study staff have also had two or more decades of familiarity with research in the study area. We recognize that our interpretations of participants’ reasons for willingness to participate in research bronchoscopy may be influenced by our position as longstanding researchers in this area. For instance, it is possible that our understanding and interpretation of some of the narratives about willingness to participate may be borne out of our bias as longstanding researchers in the area. However, we are confident in our methodological rigor such as ensuring that we used independent, trained social science research assistants to conduct the interviews. This was done in part to improve on internal validity of the interview process. We still acknowledge that for participants, there is a possibility that the association with the UCRC broader research and treatment agenda may have overridden the efforts to ensure they answer honestly about their perceptions of research bronchoscopy.

Our study is potentially influenced by adaptations of the health belief model (HBM):

Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the Health Belief Model. Health Educ Q. 1988 Summer;15(2):175-83. doi: 10.1177/109019818801500203.

Abraham, C., & Sheeran, P. (2015). The health belief model. Predicting health behaviour: Research and practice with social cognition models, 2, 30-55).

The HBM posits that individuals will seek care once the perceived risk to their health supersedes other alternatives, mainly ‘riding it out’ self-medication or treatment. Because some of the participants indicated that their willingness was influenced in part due to their prior experience seeing loved ones being treated well, and the gravity of TB, it is possible that they felt a need to also participate in efforts associated with TB control. Research bronchoscopy in this case would have been perceived in that lens, and so participants may have selected to undergo the procedure having perceived TB as so severe not to engage with care. Part of this explanation is now included in the manuscript on lines 156-160 in the analysis section and 377-384 in the discussion section.

We have attached the interview guide here for the reviewer to see the anticipated probes (prompting questions).

Comment:

2 & 3. 'The details of the analysis'. This is well addressed, but I still do not see a clear delineation of the final codes and themes identified at the completion of the rTA? If a thematic analysis has been perforrmed, can the authors say clearly what their final themes are and how they are linked?

Response:

We have added additional explanation to link the main themes to the codes (see lines 180-187 in the findings section). The major themes that emerged for willingness to participate in research bronchoscopy as derived from reasons for participation were prior experience of TB having witnessed the suffering and healing process of loved ones as they underwent treatment; a need to ‘know their health status’ given the range of tests and other care procedures associated or anticipated with being a participant on the study; and therapeutic misconception about gaining treatment despite being healthy adults without TB. An important theme was willingness to participate for altruistic reasons indicating an appreciation of how research may help generate important knowledge to improve care for future patients.

Comment:

4. 'These themes then need to pull through more strongly into the results and discussion'. The addition of more quotes really helps, thanks for this. I could still use some clearer signposting as to how the quotes chosen link directly to very clear thematic findings, but they very well articulate the broad discussion areas which are worked through.

Response:

We have added more clarity in the findings and discussion about the main themes as discussed above. Some additional subheadings and signposting has been added to link the findings to the discussion.

Comment:

5. 'The core notion of therapeutic misconception.' This was much better in this version, and I felt like I got the heart of it. The extra quotes again really helped. Annoyingly I could not see the attached codebooks on Editorial Manager which I'm sure is a software issue rather than the authors' fault!

Response:

Thank you for appreciating the additional clarity to explain the notion of therapeutic misconception. We have re-attached the codebooks and hope they will be visible/accessible.

Comment:

In summary I think this remains a great paper. I still feel the need for more critical insight into the authors' views as to why they as a research team got this data, and what data they might have missed or chosen not to elicit. I'm still left with a slightly vague feeling as to the key themes the team feel they want to highlight, and how they feel these themes might be linked in a casual or narrative model. However these things are increasingly minor points, driven by a reviewer who is interested in both the subject matter and the methodology!

Response:

Thank you for this helpful comment. We were motivated to undertake this study because of the growing use of bronchoscopy in both research and treatment contexts. But we were unaware what the community of participants in our catchment area appreciate about the procedure as used for research in healthy individuals. We needed to confirm some of the reasons for willingness to participate in an invasive procedure for research purposes when they are healthy adults without TB. All the information will help us to further improve the counseling and education sessions our investigators and staff have with research participants. We have discussed these points further in the discussion and added additional text to clarify these themes in the revised manuscript (see lines 363-384).

Reviewer #2:

Comment:

I am not too sure if I quite approve of this study. This is a research study done on healthy subjects and the authors have gone for an invasive procedure like bronchoscopy which could have been bypassed for non invasive or less invasive procedures maybe.The authors themselves have said there were lots of apprehensions regarding the procedure. Could they give more explicit details regarding whether they didn’t consider it necessary for a bystander to be accompanying the subject when they were doing an invasive procedure? If in case, there would have been complications in the event of bystanders not being there, how would they have dealt with it? How many subjects did not have bystanders accompanying them for the procedure? Was this point not raised by the IEC? This being a small study and going by what the authors say that it was done in a research sensitised area, the results cannot be generalised.

Response:

Thank you for these important observations. Fiberoptic bronchoscopy with bronchoalveolar lavage is a widely used safe method that has been used to study lung diseases such as asthma, interstitial lung disease, sarcoidosis and tuberculosis over the past 40 years. Clinical research units in South Africa and Malawi also perform research bronchoscopy with bronchoalveolar lavage in many of their studies. The main mode of transmission of tuberculosis in humans is inhalation of infectious aerosol droplet nuclei containing small numbers of viable tubercle bacilli. Initial interactions with immune cells in the lung are likely to be important and can not be studied in blood samples. The main objective of the parent study for this substudy of participant acceptability and perceptions about research bronchoscopy in healthy adults in Uganda is to study immunological responses to TB infection in the lung and blood to understand host responses to TB infection and inform the development of safer and more effective TB vaccines, a major global public health need. The parent study is sponsored by the US National Institutes of Health and has undergone full scientific and ethical review and approval in Uganda and the U.S. Two local independent medical safety monitors, who are chest physicians, monitor the study. Adverse events have been infrequent and have consisted mainly of minor self-limited sore throat and cough.

Consent for research bronchoscopy is obtained by trained nurse counselors and the investigators. Participants also receive an IRB-approved information sheet about research bronchoscopy. Participant's have multiple opportunities to ask questions and have them answered before bronchoscopy. Participants are free to withdraw from the study at any time.

Participants undergo full medical evaluation before research bronchoscopy. Research bronchoscopy is done by experienced chest physicians assisted by trained nurses with an anesthetist on standby. Participants undergo monitoring of their their pulse, blood pressure and blood oxygen saturation during bronchoscopy and are observed by medical staff for one hour after the procedure and seen in follow-up 48 to 72 hours later.

Additional Editor Comments

Comment:

Would you please respond to the comments raised by the editors and please submit the full data compilation associated with this study?

Response:

We have responded to the comments raised by the editors and submitted full data compilation for this study.

Attachment

Submitted filename: Point by Point Response to Reviewers_02082023.pdf

Decision Letter 2

Steve Zimmerman

27 Sep 2023

PONE-D-23-01054R2Perceptions about and reasons for participation in research bronchoscopy in Uganda: a qualitative analysisPLOS ONE

Dear Dr. Mafigiri,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

Your revised manuscript has been re-reviewed by reviewer #2, whose comments you can see below. This reviewer is satisfied that their earlier concerns have been addressed. However, I note that although reviewer #1 requested a copy of the interview guide, it does not appear in your submission. Please could you upload a copy of your interview guide as a supporting information file?

==============================

Please submit your revised manuscript by Nov 11 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Steve Zimmerman, PhD

Associate Editor, PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: I Don't Know

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: I think all comments have been addressed to satisfaction and it is a great paper. We perhaps need to motivate the authors to undertake more such studies so that we have a better insight into the disease.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Oct 20;18(10):e0293174. doi: 10.1371/journal.pone.0293174.r006

Author response to Decision Letter 2


2 Oct 2023

PONE-D-23-01054R2

Perceptions about and reasons for participation in research bronchoscopy in Uganda: a qualitative analysis

PLOS ONE

Response to Reviewer Comments

Associate Editor’s comments:

Comment:

Your revised manuscript has been re-reviewed by reviewer #2, whose comments you can see below. This reviewer is satisfied that their earlier concerns have been addressed.

Response:

Thank you for this positive update. We are glad that the reviewer’s comments were satisfactorily addressed and believe they improved the manuscript.

Comment:

However, I note that although reviewer #1 requested a copy of the interview guide, it does not appear in your submission. Please could you upload a copy of your interview guide as a supporting information file?

Response:

Thank you for this important observation. We have now attached both the PRE and POST bronchoscopy questionnaires.

Comment:

Please include the following items when submitting your revised manuscript:

• A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

Response:

We have included a rebuttal letter in response to the Associate Editor’s comments.

Comment:

• A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

Response:

We have not made any changes to the original version. We therefore have not attached a new/another Manuscript.

Comment:

• An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Response:

We have not made any changes to the current version. We therefore have not attached a new/another Manuscript.

Comment:

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

Response:

We have not made any changes to the financial disclosure statement as it currently stands.

Attachment

Submitted filename: Response to Reviewers_02102023.pdf

Decision Letter 3

Steve Zimmerman

9 Oct 2023

Perceptions about and reasons for participation in research bronchoscopy in Uganda: a qualitative analysis

PONE-D-23-01054R3

Dear Dr. Mafigiri,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Steve Zimmerman, PhD

Associate Editor, PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Steve Zimmerman

11 Oct 2023

PONE-D-23-01054R3

Perceptions about and reasons for participation in research bronchoscopy in Uganda: a qualitative analysis

Dear Dr. Kaawa-Mafigiri:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr Steve Zimmerman

Staff Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 File. Pre broncho questionnaire.

    (PDF)

    S2 File. Post broncho questionnaire.

    (PDF)

    Attachment

    Submitted filename: Response to Reviewers.pdf

    Attachment

    Submitted filename: Point by Point Response to Reviewers_02082023.pdf

    Attachment

    Submitted filename: Response to Reviewers_02102023.pdf

    Data Availability Statement

    The minimal, de-identified data set underlying the results of this manuscript is located on a local server at the Uganda-Case Western Reserve University Collaboration Tuberculosis Research Project Clinic’s data center. It is now available through email (data@mucwru.or.ug) upon reasonable request, with permission and notification of the Makerere University School of Social Sciences Research Ethics Committee (MAKSS REC). Any potentially identifying patient information has been fully anonymized.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES